// App-Quantinova.ai

: Expression of Myeloma Cell and Soluble B-Cell Maturation Antigen (BCMA) in Relapsed and Refractory Multiple Myeloma Patients Treated with GSK2857916 in BMA117159

Researchers

Presenter

  • E.J. Dettman

Principal Investigators

  • Fabio Rigat

  • Josh Albert

  • Ruth Barnard

  • Mary Birchler

  • Yan Deghenhardt

  • Stephen DeWall

  • Boyenoh Gaye

  • Zangdong He

  • Veronica Liu

  • Joanna Opalinska

Medical Centers

  • GlaxoSmithKline, Collegeville, PA

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • GlaxoSmithKline, King of Prussia, PA.

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Syndecan-1

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02064387

Sponsors

  • Glaxosmithkline

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved